Type I Interferons potently suppress gene expression following gene delivery using liposome–DNA complexes
Open Access
- 30 September 2005
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 12 (3) , 451-459
- https://doi.org/10.1016/j.ymthe.2005.04.008
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Non‐immunostimulatory nonviral vectorsThe FASEB Journal, 2004
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Persistent Transgene Expression Following Intravenous Administration of a Liposomal Complex: Role of Interleukin-10-Mediated Immune SuppressionMolecular Therapy, 2004
- Inhibitory effects of tumor necrosis factor-α on cationic lipid-mediated gene delivery to airway cells in vitroBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2001
- Nonspecific Inflammation Inhibits Adenovirus-Mediated Pulmonary Gene Transfer and Expression Independent of Specific Acquired Immune ResponsesHuman Gene Therapy, 1998
- Neutralization of Endogenous Interferon-β Increases the Efficiency of Adenoviral Vector-Mediated Gene TransductionJournal of Interferon & Cytokine Research, 1997
- Immune Defence in Mice Lacking Type I and/or Type II Interferon ReceptorsImmunological Reviews, 1995
- Induction of apoptosis in mature T cells by tumour necrosis factorNature, 1995
- Functional Role of Type I and Type II Interferons in Antiviral DefenseScience, 1994
- Effect of Interferon-α on Immediate Early Gene Expression of Murine CytomegalovirusJournal of Interferon Research, 1993